Evaluation of acotiamide for the treatment of functional dyspepsia.

about

Emerging drugs for functional dyspepsia.Safety of treatment for gastroparesis.Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.

P2860

Q38342083-C40C6B9D-67EF-4D86-9C89-747C29144839 Q38794290-8890E255-2A21-460E-9893-A54529C104ED Q43093685-D1FB9344-5A2B-44B0-870B-48A53090C411

P2860

Evaluation of acotiamide for the treatment of functional dyspepsia.

Item

http://www.wikidata.org/entity/Q38216446

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Evaluation of acotiamide for the treatment of functional dyspepsia.

@en

type

Item

label

Evaluation of acotiamide for the treatment of functional dyspepsia.

@en

prefLabel

Evaluation of acotiamide for the treatment of functional dyspepsia.

@en

P1476

Evaluation of acotiamide for the treatment of functional dyspepsia.

@en

P2093

Gengqing Song

http://www.w3.org/2001/XMLSchema#string

Richard W McCallum

http://www.w3.org/2001/XMLSchema#string

Yan Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: current treatment options and management of functional dyspepsia

Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia.

Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage.

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.

Tricyclic antidepressants for chronic vomiting in diabetic patients.

A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

The risks of PPI therapy.

Proton pump inhibitors: potential adverse effects.

Current management strategies and emerging treatments for functional dyspepsia.

P304

1161-1168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2014.920320

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24881488

http://www.w3.org/2001/XMLSchema#string

Evaluation of acotiamide for the treatment of functional dyspepsia.

about

P2860

P2860

Evaluation of acotiamide for the treatment of functional dyspepsia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698